24×7 Online Assistance Email researchnnnn@gmail.com WhatsApp support Hours 24×7
MD · Para-clinical

Adverse Drug Reactions Thesis Topics for MD Pharmacology — 30+ titles

Updated November 2026 · reviewed against the current NMC / NBE curriculum

Hand-curated database of 30+ MD Pharmacology (Adverse Drug Reactions) dissertation titles, each ready with objectives, synopsis structure and protocol guidance. Unlock the objectives of any title instantly, or get the complete thesis plan — no signup.

30+MD Pharmacology (Adverse Drug Reactions) titles
24×7Instant objectives & thesis plans
100%Plagiarism-free, IEC-ready
Browse all 30 titles See a full thesis plan
Adverse Drug Reactions thesis topics

MD Pharmacology (Adverse Drug Reactions) — Thesis Title List

30 titles · instant objectives
  1. 001

    Pattern, causality and severity of adverse drug reactions reported at an ADR monitoring centre of a tertiary care hospital

    Adverse Drug Reactions Prospective observational study Pharmacovigilance Study
    Objective
  2. 002

    Adverse drug reactions to first-line anti-tubercular therapy under the NTEP and their impact on treatment adherence

    Adverse Drug Reactions Prospective observational study Pharmacovigilance Study
    Objective
  3. 003

    Cutaneous adverse drug reactions: clinical pattern, causative drugs and causality assessment using WHO-UMC and Naranjo scales

    Adverse Drug Reactions Prospective observational study Pharmacovigilance Study
    Objective
  4. 004

    Adverse drug reactions to cancer chemotherapy in the oncology day-care unit: pattern, severity and preventability

    Adverse Drug Reactions Prospective observational study Pharmacovigilance Study
    Objective
  5. 005

    Knowledge, attitude and practice of adverse drug reaction reporting among resident doctors and nurses and effect of an educational intervention

    Adverse Drug Reactions Pre-post interventional study KAP Study
    Objective
  6. 006

    Adverse drug reactions to antiretroviral therapy and their association with treatment regimen and CD4 count

    Adverse Drug Reactions Prospective observational study Pharmacovigilance Study
    Objective
  7. 007

    Adverse events following immunisation reported at a tertiary care hospital: pattern and causality assessment

    Adverse Drug Reactions Prospective observational study Pharmacovigilance Study
    Objective
  8. 008

    Drug-induced hepatotoxicity in patients on anti-tubercular therapy: incidence, risk factors and outcome

    Adverse Drug Reactions Prospective observational study Prospective Study
    Objective
  9. 009

    Adverse drug reactions associated with all-oral regimens for drug-resistant tuberculosis: a prospective pharmacovigilance study

    Adverse Drug Reactions Prospective observational study Pharmacovigilance Study
    Objective
  10. 010

    Adverse drug reactions, medication adherence and quality of life in patients with carcinoma breast on chemotherapy

    Adverse Drug Reactions Prospective observational study Pharmacovigilance Study
    Objective
  11. 011

    Seriousness and preventability of adverse drug reactions in hospitalised patients assessed by modified Schumock and Thornton criteria

    Adverse Drug Reactions Prospective observational study Pharmacovigilance Study
    Objective
  12. 012

    Adverse drug reactions in patients with respiratory diseases: pattern, severity and predictors

    Adverse Drug Reactions Prospective observational study Pharmacovigilance Study
    Objective
  13. 013

    Metabolic adverse effects of second-generation antipsychotics in patients with schizophrenia

    Adverse Drug Reactions Prospective observational study Pharmacovigilance Study
    Objective
  14. 014

    Adverse drug reactions in paediatric inpatients: incidence, pattern and causality assessment

    Adverse Drug Reactions Prospective observational study Pharmacovigilance Study
    Objective
  15. 015

    Adverse drug reactions in elderly inpatients and their association with polypharmacy

    Adverse Drug Reactions Prospective observational study Pharmacovigilance Study
    Objective
  16. 016

    Adverse events of sodium-glucose cotransporter-2 inhibitors in patients with type 2 diabetes mellitus

    Adverse Drug Reactions Prospective observational study Pharmacovigilance Study
    Objective
  17. 017

    Trends in spontaneous adverse drug reaction reporting at a newly established ADR monitoring centre over two years

    Adverse Drug Reactions Retrospective record-based study Pharmacovigilance Study
    Objective
  18. 018

    Drug-induced QT prolongation in hospitalised patients receiving QT-prolonging drugs

    Adverse Drug Reactions Prospective observational study Pharmacovigilance Study
    Objective
  19. 019

    Adverse drug reactions to antiepileptic drugs in children: pattern and causality assessment

    Adverse Drug Reactions Prospective observational study Pharmacovigilance Study
    Objective
  20. 020

    Incidence, implicated drugs and preventability of adverse drug reaction-related hospital admissions at a tertiary-care hospital

    Adverse Drug Reactions Prospective observational study Pharmacovigilance Study
    Objective
  21. 021

    Potential drug-drug interactions and adverse drug reactions in elderly psychiatric outpatients receiving antipsychotics

    Adverse Drug Reactions Cross-sectional study Pharmacovigilance Study
    Objective
  22. 022

    Incidence and risk factors of anthracycline-induced cardiotoxicity assessed by echocardiography and troponin in women with breast cancer

    Adverse Drug Reactions Prospective observational study Pharmacovigilance Study
    Objective
  23. 023

    Drug-induced extrapyramidal reactions to antiemetics and antipsychotics among patients presenting to the emergency department

    Adverse Drug Reactions Prospective observational study Pharmacovigilance Study
    Objective
  24. 024

    Spectrum, causative drugs and SCORTEN-based outcome of severe cutaneous adverse drug reactions in hospitalised patients

    Adverse Drug Reactions Prospective observational study Pharmacovigilance Study
    Objective
  25. 025

    Pattern, severity and preventability of adverse drug reactions in hospitalised paediatric cancer patients at a tertiary-care teaching hospital

    Adverse Drug Reactions Prospective observational study Pharmacovigilance Study
    Objective
  26. 026

    Medication regimen complexity index and hospitalisation due to adverse drug reactions in people living with HIV on antiretroviral therapy

    Adverse Drug Reactions Prospective observational study Pharmacovigilance Study
    Objective
  27. 027

    Inter-rater agreement between the WHO-UMC system and the Naranjo algorithm for causality assessment of adverse drug reactions reported at an ADR monitoring centre

    Adverse Drug Reactions Retrospective record-based study Pharmacovigilance Study
    Objective
  28. 028

    Health-related quality of life and its determinants in patients experiencing adverse drug reactions at a tertiary-care hospital

    Adverse Drug Reactions Cross-sectional study Cross-sectional Study
    Objective
  29. 029

    Nephrotoxicity and electrolyte disturbances with amphotericin B formulations in patients with invasive fungal infections: a prospective pharmacovigilance study

    Adverse Drug Reactions Prospective observational study Pharmacovigilance Study
    Objective
  30. 030

    Effect of a sensitisation session on knowledge and attitude of school teachers towards reporting adverse events during mass deworming

    Adverse Drug Reactions Pre-post interventional study Interventional Study
    Objective

MD Pharmacology (Adverse Drug Reactions) thesis — frequently asked questions

How many MD Pharmacology (Adverse Drug Reactions) thesis topics are listed here?

30+ MD Pharmacology (Adverse Drug Reactions) thesis topics are listed on this page, organised by subsection of the Pharmacology (Adverse Drug Reactions) curriculum. Click "Get Objectives" on any title to unlock its aim, objectives and hypothesis instantly.

Do these Pharmacology (Adverse Drug Reactions) topics include the objective and synopsis?

Yes. "Get Objectives" unlocks the research question, aim, primary and secondary objectives, hypothesis and outcome measures. "Full Plan" unlocks the complete synopsis: introduction, review of literature search terms, methodology, sample-size calculation, statistical plan, ethics and timeline — ready to download as Word or PDF.

Are these topics suitable for DNB, MD and FCPS Pharmacology (Adverse Drug Reactions) candidates?

Yes — these Pharmacology (Adverse Drug Reactions) dissertation titles are aligned with NMC, NBE and DNB Pharmacology (Adverse Drug Reactions) curricula and are suitable for MD Pharmacology (Adverse Drug Reactions), DNB Pharmacology (Adverse Drug Reactions) and FCPS candidates alike. We can also tailor a title to your institution's preferred study design.

Can you help with synopsis writing, protocol, data analysis and journal publication?

Yes. Beyond topic selection we provide end-to-end support: synopsis writing (NMC / NBE format), IEC / IRB-ready protocol drafting, data collection forms, statistical analysis (SPSS / R / STATA), full thesis writing, plagiarism check (Turnitin), and journal publication assistance (SCOPUS, UGC-CARE, PubMed-indexed).

How fast can I get the objective for a topic?

Instantly. After payment, the objectives open on screen in under a minute and the full plan in 1–3 minutes, 24×7. You can also click "WhatsApp" on any title to talk to our team.

WhatsApp